-
A ranar 20 ga Agusta, 2025, Abbisko Therapeutics ta sanar da cewa Cibiyar Kimanta Magunguna (CDE) ta Hukumar Kayayyakin Lafiya ta Kasa ta China (NlPA) ta amince da aikace-aikacen lND don maganin hana PD-1 na Abbisko, ABSK043, tare da Shanghai Alist Pharmaceuticals KRAS ...Kara karantawa»
-
Kwanan nan, binciken Antengene's Phase I/II CLINCH na ATG-022 (CLDN18.2 antibody-drug conjugate), wani tsofaffi da ke fama da ciwon daji na ciki wanda ya ci gaba da samun nau'ikan chemotherapy da yawa, immunotherapy da kuma magani mai niyya duk da yawan metastases da aka samu, ya sami cikakken amsa (CR) bayan...Kara karantawa»
-
A ranar 13 ga Agusta, 2025, Pacific Time, gidan yanar gizon hukuma na taron duniya na 2025 kan cutar kansar huhu (WCLC) ya fitar da taƙaitaccen bayani game da binciken da aka zaɓa don taron na wannan shekara, Daga cikin abubuwan da suka fi jan hankali akwai sabon taƙaitaccen bayani game da gwajin asibiti na farko a cikin ɗan adam na HLX43, Henlius' PD-L1 ADC. A...Kara karantawa»
-
A ranar 7 ga watan Agusta, Cibiyar Kimanta Magunguna (CDE) ta Hukumar Kayayyakin Lafiya ta Kasa (NMPA) ta sanar da cewa an gabatar da allurar PA3-17 don haɗawa a cikin tsarin maganin gaggawa, wanda aka yi niyya don maganin manya marasa lafiya da suka sake dawowa/rage yawan cutar lymph...Kara karantawa»
-
A ranar 11 ga watan Agusta, Cibiyar Kimanta Magunguna (CDE) ta Hukumar Kula da Kayayyakin Lafiya ta Kasa (NMPA) ta nuna cewa an gabatar da aikace-aikacen InxMed na allunan IN10018 don tantance maganin nasara, wanda aka yi niyya don haɗawa da D-1553 don magance KRA mai ci gaba ko kuma wanda ya kamu da cutar...Kara karantawa»
-
Mista X majiyyaci ne mai shekaru 40 da haihuwa wanda aka gano yana da cutar acral melanoma. Bayan an yi masa tiyata mai tsanani bayan an gano cutar a shekarar 2015, yanayinsa ya daidaita tsawon shekaru tara. Abin takaici, kimanin shekara guda da ta wuce, cutar ta sake bulla tare da kamuwa da cutar a huhu. Duk da samun cutar a cikin hanji da kuma ƙashin ƙugu...Kara karantawa»
-
A ranar 31 ga Yuli, AstraZeneca da Merck & Co. sun sanar da cewa an amince da maganin hana PARP Lynparza, tare da Abiraterone da prednisolone, a China don maganin manya da ke fama da cutar kansar mafitsara mai jure castration (mCRPC) waɗanda ke ɗauke da cutar germline ko wasu...Kara karantawa»
-
A ranar 31 ga Yuli, 2025, ImmuneOnco Biopharmaceuticals ta sanar da bayanai na farko game da aminci da inganci daga binciken IMM2510 mai lakabin mataki na 2, wanda aka yi a cibiyoyi da dama tare da maganin chemotherapy ga marasa lafiya da ke fama da cutar kansar huhu ta hanyar ƙwayoyin cuta (NSCLC) da aka gudanar a China. Tun daga ranar 1 ga Yuli, 2025,...Kara karantawa»
-
A ranar 30 ga Yuli, Hukumar Kayayyakin Lafiya ta Ƙasa (NMPA) ta amince da tallan HICARA a hukumance don maganin manyan marasa lafiya da suka sake kamuwa da cutar lymphoma mai girma na B-cell (r/r LBCL) waɗanda suka sami layuka biyu ko fiye na maganin tsari. Wannan ya haɗa da manyan ƙwayoyin B-cell da ke yaɗuwa ...Kara karantawa»
-
Kwanan nan, wani majiyyaci da ke fama da cutar kansar pancreas wanda ya kasa samun magani da yawa a baya ya sami raguwar ciwon daji bayan ya sami maganin ƙwayoyin CAR-T na KD-496, tare da tabbatar da cewa an sami sassauci bayan kwana 180 bayan magani. A halin yanzu, har yanzu akwai gwaje-gwaje da yawa na asibiti na sabbin...Kara karantawa»
-
A ranar 16 ga Yuli, wata babbar mujallar kasa da kasa mai suna Nature Medicine ta buga bayanan bincike kan SHR-A1904, wani maganin rigakafi da maganin rigakafi (ADC) wanda ke nufin claudin 18.2 (CLDN18.2), don magance cutar kansar ciki ko kuma cutar kansar gastroesophageal junction (GC/GEJC). Masu binciken sun gudanar da wani gwaji na farko a...Kara karantawa»
-
17 ga Yuli, 2025 – Innovent Biologics ta sanar da cewa Nature Medicine ta buga sakamakon binciken asibiti na Mataki na 1 na IBI343, wani sabon maganin hana CLDN18.2 ADC, don maganin adenocarcinoma na ciwon ciki/gastroesophageal junction (G/GEJ). An buga a cikin wannan babban...Kara karantawa»
Cibiyar likitanci ta haɗin gwiwa ta Asibitin Ciwon Daji na Beijing